New York State Common Retirement Fund’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Sell |
11,746
-4,689
| -29% | -$108K | ﹤0.01% | 2129 |
|
|
2025
Q1 | $444K | Buy |
16,435
+471
| +3% | +$12.7K | ﹤0.01% | 1923 |
|
|
2024
Q4 | $855K | Buy |
15,964
+7,318
| +85% | +$392K | ﹤0.01% | 1746 |
|
|
2024
Q3 | $393K | Sell |
8,646
-2,900
| -25% | -$132K | ﹤0.01% | 2026 |
|
|
2024
Q2 | $484K | Buy |
11,546
+4,307
| +59% | +$181K | ﹤0.01% | 2054 |
|
|
2024
Q1 | $273K | Buy |
7,239
+2,189
| +43% | +$82.6K | ﹤0.01% | 2308 |
|
|
2023
Q4 | $54K | Sell |
5,050
-35
| -0.7% | -$374 | ﹤0.01% | 2970 |
|
|
2023
Q3 | $51K | Buy |
5,085
+55
| +1% | +$552 | ﹤0.01% | 3017 |
|
|
2023
Q2 | $60K | Sell |
5,030
-8,218
| -62% | -$98K | ﹤0.01% | 3093 |
|
|
2023
Q1 | $160K | Buy |
13,248
+13
| +0.1% | +$157 | ﹤0.01% | 2683 |
|
|
2022
Q4 | $174K | Sell |
13,235
-24
| -0.2% | -$316 | ﹤0.01% | 2786 |
|
|
2022
Q3 | $180K | Buy |
13,259
+5,246
| +65% | +$71.2K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $98K | Sell |
8,013
-7,508
| -48% | -$91.8K | ﹤0.01% | 3065 |
|
|
2022
Q1 | $223K | Buy |
15,521
+6,000
| +63% | +$86.2K | ﹤0.01% | 2783 |
|
|
2021
Q4 | $188K | Buy |
9,521
+7,221
| +314% | +$143K | ﹤0.01% | 2895 |
|
|
2021
Q3 | $50K | Buy |
+2,300
| New | +$50K | ﹤0.01% | 3240 |
|